As of July 18, 2007, Ilypsa, Inc. was acquired by Amgen Inc. Ilypsa, Inc. discovers and develops renal care pharmaceutical products. It develops non-absorbed polymeric phosphate and potassium binder compounds to treat chronic kidney diseases. The company, formerly known as Symyx Therapeutics, Inc. was founded in 2002 and is based in Santa Clara, California.
Amgen buys kidney-disease biotech Ilypsa for $420M (venturebeat.com) 
Recent Incoming Links